Education
About Us
Working with TipRanks
Follow Us
Resonance Health Ltd (AU:RHT)
ASX:RHT
Total Valuation
Resonance Health Ltd has a market cap or net worth of AU$23.25M. The enterprise value is AU$18.76M.
Market CapAU$23.25M
Enterprise ValueAU$18.76M
Share Statistics
Resonance Health Ltd has 474,509,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding474,509,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Resonance Health Ltd’s return on equity (ROE) is -0.18 and return on invested capital (ROIC) is -17.72%.
Return on Equity (ROE)-0.18
Return on Assets (ROA)-0.10
Return on Invested Capital (ROIC)-17.72%
Return on Capital Employed (ROCE)-0.15
Revenue Per Employee615.17K
Profits Per Employee-96.27K
Employee Count18
Asset Turnover0.62
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Resonance Health Ltd is ―. Resonance Health Ltd’s PEG ratio is 0.00976.
PE Ratio―
PS Ratio1.60
PB Ratio1.89
Price to Fair Value1.89
Price to FCF22.05
Price to Operating Cash Flow18.43
PEG Ratio0.00976
Income Statement
In the last 12 months, Resonance Health Ltd had revenue of 11.07M and earned -1.73M in profits. Earnings per share was 0.00.
Revenue11.07M
Gross Profit11.07M
Operating Income-1.93M
Pretax Income-2.20M
Net Income-1.73M
EBITDA-1.41M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 1.25M and capital expenditures -443.12K, giving a free cash flow of 805.39K billion.
Operating Cash Flow1.25M
Free Cash Flow805.39K
Free Cash Flow per Share<0.01
Dividends & Yields
Resonance Health Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.32
52-Week Price Change-16.67%
50-Day Moving Average0.05
200-Day Moving Average0.04
Relative Strength Index (RSI)53.79
Average Volume (3m)274.25K
Important Dates
Resonance Health Ltd upcoming earnings date is Feb 20, 2026, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateFeb 20, 2026
Ex-Dividend Date―
Financial Position
Resonance Health Ltd as a current ratio of 1.28, with Debt / Equity ratio of 40.49%
Current Ratio1.28
Quick Ratio1.28
Debt to Market Cap0.16
Net Debt to EBITDA-0.59
Interest Coverage Ratio-6.05
Taxes
In the past 12 months, Resonance Health Ltd has paid 465.93K in taxes.
Income Tax465.93K
Effective Tax Rate-0.21
Enterprise Valuation
Resonance Health Ltd EV to EBITDA ratio is -13.20, with an EV/FCF ratio of 23.07.
EV to Sales1.68
EV to EBITDA-13.20
EV to Free Cash Flow23.07
EV to Operating Cash Flow14.88
Balance Sheet
Resonance Health Ltd has AU$2.98M in cash and marketable securities with AU$3.80M in debt, giving a net cash position of -AU$826.09K billion.
Cash & Marketable SecuritiesAU$2.98M
Total DebtAU$3.80M
Net Cash-AU$826.09K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 100.00%, with operating margin of -17.42%, and net profit margin of -15.65%.
Gross Margin100.00%
Operating Margin-17.42%
Pretax Margin-19.86%
Net Profit Margin-15.65%
EBITDA Margin-12.72%
EBIT Margin-14.30%
Analyst Forecast
The average price target for Resonance Health Ltd is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast28.91%
EPS Growth Forecast-1050.00%